Study guide
IFIS, capsule rupture and compromised support
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
IFIS, capsule rupture and compromised support
Key Takeaways Explain This Topic AI
Past as well as current alpha-antagonist exposure can be relevant to IFIS risk.
Suspected capsule rupture requires chamber stabilization before withdrawing instruments and controlled vitreous management.
An IOL suitable for the bag may be unsuitable for the sulcus; support determines fixation choice.
Last updated: October 2026
Intraoperative Floppy Iris Syndrome (IFIS)
First characterized by David Chang and John Campbell in 2005, Intraoperative Floppy Iris Syndrome (IFIS) is an unpredictable, potentially sight-threatening intraoperative condition occurring in patients exposed to systemic α 1 \alpha_1 α 1 -adrenergic receptor antagonists.
The Clinical Triad of IFIS
Flaccid Iris Stroma: The iris stroma billows, waves, and ripples in response to ordinary, gentle intraocular irrigation currents.
Propensity for Iris Prolapse: The loose iris tissue repeatedly herniates toward and prolapses out of the clear corneal and paracentesis incisions.
Progressive Intraoperative Miosis: The pupil constricts progressively throughout surgery despite aggressive, full preoperative pharmacological mydriasis.
Pharmacological Mechanism & The Tamsulosin Rule
Receptor Selectivity: The iris dilator smooth muscle is innervated by sympathetic fibers acting on α 1 A \alpha_{1A} α 1 A -adrenergic receptors . Tamsulosin (Flomax) is a subtype-selective antagonist with high affinity for α 1 A \alpha_{1A} α 1 A and α 1 D \alpha_{1D} α 1 D receptors, widely prescribed for benign prostatic hyperplasia (BPH) and lower urinary tract symptoms.
Other associations: Other alpha-1 antagonists, including silodosin (also relatively alpha-1A selective), and some psychoactive medicines can be associated with IFIS. Risk varies by drug and population; a universal greater-than-85% occurrence is inappropriate. Ask about past as well as current exposure.
Structural Dilator Muscle Atrophy: Chronic receptor blockade causes permanent, structural disuse atrophy and tone loss in the iris dilator muscle.
The Irreversibility Rule: Discontinuing tamsulosin prior to surgery does NOT prevent IFIS . Structural muscular atrophy persists for years after drug cessation. Patients who stopped tamsulosin years before cataract extraction remain at full risk for severe IFIS.
Intraoperative Management Protocol
Preoperative Preparation: Topical atropine 1 % 1\% 1% drops twice daily for 2 to 3 days prior to surgery provides competitive muscarinic blockade, inducing maximal cycloplegia and stabilizing iris tone.
Intracameral mydriatic preparations require a validated pharmacy formulation and local protocol.
Viscoadaptive OVDs: Highly viscous OVDs (e.g., Healon5) can be used to viscodilate and physically tamponade the iris.
Mechanical Pupil Expansion Devices:
Malyugin Ring: A square polypropylene expansion ring with four circular micro-scrolls that cradle the pupillary margin, maintaining an unyielding 6.25 mm 6.25\text{ mm} 6.25 mm or 7.0 mm 7.0\text{ mm} 7.0 mm round aperture.
Flexible Iris Retractors (Hooks): Four disposable retractors placed through dedicated stab paracenteses. Placing the sub-incisional hook directly beneath the main clear corneal incision in a "diamond" layout retracts the sub-incisional iris, completely eliminating iris prolapse into the phaco tunnel.
Low-Flow Fluidics: Decreasing aspiration flow rate ( 20 − 25 mL/min 20-25\text{ mL/min} 20 − 25 mL/min ) and lowering bottle height minimizes intraocular turbulence.
Posterior Capsule Rupture (PCR) & Vitreous Loss Management
Posterior capsule rupture occurs in approximately 1 to 2 % 1\text{ to }2\% 1 to 2% of routine cataract procedures performed by experienced surgeons, but escalates to 5 to 10 % 5\text{ to }10\% 5 to 10% in complex cases (pseudoexfoliation syndrome, posterior polar cataract, prior vitrectomy, traumatic zonular dialysis, dense brunescent cataracts).
Warning Signs of Posterior Capsule Rupture
Sudden, unexplained deepening or shallowing of the anterior chamber.
Sudden loss of fragment followability (debris refuses to approach the aspiration port).
Momentary pupillary snap or bounce.
Nuclear fragment tilting, sinking, or drifting away from the phaco tip.
Direct visualization of a torn capsular edge or a halo/bubble around the aspiration port.
The Golden Rule of PCR: DO NOT WITHDRAW THE PHACO TIP ABRUPTLY!
Caution
The instantaneous reflex of an inexperienced surgeon upon noticing a capsule tear is to release the foot pedal and withdraw the phaco tip from the eye. This is a catastrophic error.
Mechanism of Disaster: Withdrawing the phaco tip without active infusion causes immediate anterior chamber decompression and pressure collapse. Vitreous from the high-pressure vitreous cavity instantly surges forward through the capsular rent into the anterior chamber, transforming a small, manageable tear into a massive capsular disaster, shearing zonules, prolapsing vitreous through the corneal wounds, and dropping remaining nuclear fragments into the posterior segment.
The Correct Emergency Protocol:
Maintain Foot Position 1 (Irrigation Active): Keep the phaco tip steady in the eye with continuous irrigation running to maintain anterior chamber depth and counter vitreous upthrust.
Inject Dispersive OVD Before Tip Withdrawal: Using the non-dominant hand, introduce a cannula through the paracentesis and inject a dispersive OVD (Viscoat) directly beneath the remaining lens fragments and over the capsular tear. The OVD tamponades the anterior vitreous face, pushes vitreous backward, stabilizes the fragments, and creates an artificial protective barrier.
Withdraw Tip Under OVD Cushion: Only after the anterior chamber is completely filled with OVD and the vitreous face is sealed may the phaco tip be safely removed.
Principles of Anterior Vitrectomy
Once vitreous has prolapsed into the anterior chamber, the goal shifts to thorough, traction-free clearance of vitreous from the anterior segment and surgical wounds:
Separate infusion and cutting help control chamber stability and minimise traction; a limbal or pars plana approach requires appropriate training and anatomy.
Settings: Use a suitable high cut rate with controlled aspiration and infusion for the platform. Cutting before significant aspiration reduces traction; numerical settings and mode names are machine-specific.
Visualisation: An appropriate preservative-free triamcinolone preparation can reveal vitreous strands. Follow validated preparation and dilution instructions rather than treating one concentration as universal.
Completion: Inspect the pupil and wounds, chamber and remaining capsule. A round pupil alone does not prove that every vitreous strand has been cleared.
Secondary IOL Selection & Fixation with Compromised Capsular Support
Assess the anterior capsular rim, zonules, vitreous clearance, iris and endothelium before implantation. With suitable anterior support, a sulcus-compatible three-piece lens may be used. Optic capture through an intact appropriately sized anterior capsulorhexis can improve centration and place the optic close to the bag plane.
Bag-designed single-piece acrylic lenses are unsuitable for the sulcus: thick haptics and optic edges can chafe the iris, causing pigment dispersion, recurrent bleeding, inflammation, pressure elevation and cystoid macular oedema (uveitis-glaucoma-hyphaema syndrome). Compatibility depends on the actual IOL design, not simply the number of pieces.
An optic wholly in the sulcus is more anterior and may require a power reduction; use an appropriate calculation for the lens power and position. Do not apply a universal 0.5 D reduction. With optic capture and a bag-plane optic, adjustment is often unnecessary.
If support is insufficient, options include an anterior-chamber lens in a suitable eye, iris fixation or scleral fixation. Evaluate angle and endothelial status, iris integrity and surgical risks. Anterior-chamber designs may require an iridectomy. Aphakia with delayed secondary implantation can be safer than forcing an unstable lens during complicated surgery.